Please assess the completion status of the following clinical trial:

Trial Title: Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients between 18 and 80 years (inclusive);~* proven or suspected infection;~* meeting 2 of 4 of the systemic inflammatory response syndrome (SIRS) criteria;~* septic shock or one or more acute organ failures in the preceding 12 hours;~* written informed consent obtained.~Exclusion Criteria:~* Pregnant or lactating women;~* known HIV seropositive patients;~* patients receiving immunosuppressive therapy or chronically using high doses of glucocorticosteroids (defined as \> 1 mg/kg/day) equivalent to prednisone 1 mg/kg/day;~* patients expected to have rapidly fatal disease within 24 h;~* known confirmed gram-positive sepsis;~* known confirmed fungal sepsis;~* chronic renal failure requiring haemodialysis or peritoneal dialysis;~* acute pancreatitis with no established source of infection;~* patients not expected to survive for 28 days due to other medical conditions such as end-stage neoplasm or other diseases;~* participation in another investigational study within 90 days prior to start of the study which might interfere with this study;~* previous administration of AP;~* known allergy for cow milk.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): BIAP
- Placebo (Type: PLACEBO_COMPARATOR): Placebo, saline

Based on this trial design, predict the completion outcome and termination type (if applicable).